Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Cipla
Street 1: Mumbai Central
Street 2:
City: MUMBAI
Province:
Post Code: 400.008
Country: India
Phone: +91 22 23082891
Organization Email: sharadd.jain@cipla.com
Web Site: http://www.cipla.com
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Denis
Last Name: Broun
Title: Director of public and government affairs
Email: denis.broun@cipla.com
Phone: +41.79.261.3137

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Sharadd
Last Name: Jain
Title: Director Global Access
Email: sharadd.jain@cipla.com
Phone: +91.88791.24364

General Information

Board Constituency: Private sector
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
Manufacturer of high quality medicines
Manufacturer of anti-TB drugs
Supplying TB drugs to low-income countries through our Global Access programme and supporting the development of new therapies for MDR-TB
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Provision of drugs, diagnostics and commodities

Other Organization Information

Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 26 - 50
Number of part-time staff who are directly involved with TB: 100 +
Number of volunteers who are directly involved with TB: 0
 
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
SUpport through interaction with the national authorities in charge of the RNTCP and provision of medicines through government tenders
 

Geographical Reach

Which country is your headquarters located in: India
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Afghanistan
Angola
Bangladesh
Bhutan
Burundi
Cambodia
Cameroon
Cape Verde
Central African Republic
Chad
Congo
Cote d'Ivoire
Democratic Republic of the Congo
Djibouti
Equatorial Guinea
Eswatini
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Haiti
India
Indonesia
Iran (Islamic Republic of)
Kazakhstan
Kenya
Kyrgyzstan
Lao People's Democratic Republic
Lesotho
Liberia
Madagascar
Malawi
Malaysia
Mali
Mauritania
Mauritius
Mexico
Mongolia
Morocco
Mozambique
Namibia
Nepal
Niger
Nigeria
Pakistan
Papua New Guinea
Peru
Philippines
Republic of Moldova
Russian Federation
Rwanda
Senegal
Seychelles
Sierra Leone
South Africa
South Sudan
Sri Lanka
Sudan
Switzerland
Tajikistan
Thailand
Tunisia
Turkey
Turkmenistan
Uganda
Ukraine
United Arab Emirates
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America
Uzbekistan
Venezuela
Viet Nam
Yemen
Zambia
Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Supply of 7 anti-TB products used in MDR-TB

TB-HIV:
Second largest supplier of ARV in the world

New TB Drugs:
Involved in R&D for new TB products

Declaration

Declaration of interests:
CIPLA is a pharmaceutical company sellin medicines, including TB medicines. In addition, CIPLA participates in GDF tenders.


Application date: March 14, 2015
Last updated: April 20, 2018